Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. New
treatment options are becoming available, and there is a need to characterize the …

Abstract Hepatitis B (HB) virus (HBV) infection, which causes liver cirrhosis and
hepatocellular carcinoma, is endemic worldwide. Hepatitis B vaccines became commercially …

The disease burden of hepatitis C virus (HCV) is expected to increase as the infected
population ages. A modelling approach was used to estimate the total number of viremic …

Background While the numbers of hepatitis-C-virus (HCV) infections among men who have
sex with men (MSM) who are co-infected with the human immunodeficiency virus (HIV) are …

Background Understanding the patterns and trends in the context of both incidence and
mortality and anticipating future trends is important for viral hepatitis prevention, treatment …

Background Chronic hepatitis C virus infection is a major cause of liver disease in
Switzerland and carries a significant cost burden. Currently, only conservative strategies are …

In this multi‐method study, we investigated the prevalence of chronic infections with the
hepatitis C virus (HCV) in Switzerland in 2020, and assessed Switzerland's progress in …

Abstract Background Hepatitis C virus (HCV) infections are a public health burden
worldwide and often go undetected until sequelae develop. Offering HCV screening for the …

With an estimated antibody prevalence of 0.7% in the low-risk population, hepatitis C virus
(HCV) endemicity in Switzerland is low. We reviewed data from mandatory hepatitis C …

BACKGROUND: With the invasion of Ukraine by the Russian Army in February 2022,
refugees, the majority of whom are women and children, started fleeing the war to …